22 results
8-K
EX-3.1
VYNE
VYNE Therapeutics Inc
10 Feb 23
Material Modifications to Rights of Security Holders
5:01pm
8-K
EX-3.1
VYNE
VYNE Therapeutics Inc
17 Jan 23
Amendments to Articles of Incorporation or Bylaws
5:15pm
10-Q
2022 Q3
EX-3.2
VYNE
VYNE Therapeutics Inc
Quarterly report
14 Nov 22
4:15pm
10-Q
2022 Q3
EX-3.1
VYNE
VYNE Therapeutics Inc
Quarterly report
14 Nov 22
4:15pm
10-K
2021 FY
EX-3.1
VYNE
VYNE Therapeutics Inc
Annual report
17 Mar 22
4:10pm
8-K
EX-3.1
d5tpby
19 Jul 21
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
EX-3.1
wad4wbjmqksjbsq3 xx
12 Feb 21
Material Modifications to Rights of Security Holders
5:00pm
8-K
EX-3.1
5kdwirpazt8jfp
8 Sep 20
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
8:21am
8-K
EX-3.2
hannwbn p33g
8 Sep 20
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
8:21am
8-K
EX-3.1
nu5zdz
6 Apr 20
Menlo Therapeutics Announces Results from Two Phase 3 Clinical Trials of Serlopitant for the Treatment of Pruritus Associated with Prurigo Nodularis
9:00am
8-K
EX-3.2
jbp6zcps79dn8w13e
29 Jan 18
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock
12:00am
8-K
EX-3.1
5l3kx9sf
29 Jan 18
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock
12:00am
S-1/A
EX-3.2
lxsi0axx
12 Jan 18
IPO registration (amended)
12:00am
S-1
EX-3.1
tfee04jxf4ii6n8k77
28 Dec 17
IPO registration
12:00am
S-1
EX-3.5
968wl3c1zky3n0m
28 Dec 17
IPO registration
12:00am
S-1
EX-3.4
8ussz2oy8 riu3mpzeqw
28 Dec 17
IPO registration
12:00am
S-1
EX-3.3
y2zw2dw1d5
28 Dec 17
IPO registration
12:00am